Arkolith/Insider Trading/INM/Form 4

ADAR1 Capital Management, LLC

10% OwnerInMed Pharmaceuticals Inc. (INM) · full profile →Form 4 · filed May 21, 2026
Net Buying
Open-Market Buys
$722K
Open-Market Sells
$0
Net Open-Market Flow
$722K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2026Buy(P)69K$1.60$110K400K
May 19, 2026Buy(P)200K$1.56$312K600K
May 19, 2026Buy(P)200K$1.50$300K800K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001940272-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for InMed Pharmaceuticals Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp